| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 08/16/2001 | WO2001059127A2 Drug metabolizing enzymes |
| 08/16/2001 | WO2001059081A2 Methods for using 20893, a human protein kinase |
| 08/16/2001 | WO2001059071A2 Methods of preparing and using a viral vector library |
| 08/16/2001 | WO2001058956A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | WO2001058954A2 Trade molecules and uses related thereto |
| 08/16/2001 | WO2001058949A2 Heterologous polypeptide of the tnf family |
| 08/16/2001 | WO2001058945A1 Dna encoding human vanilloid receptor vr3 |
| 08/16/2001 | WO2001058927A1 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 08/16/2001 | WO2001058922A2 Method and compositions for treating hepatocellular cancer |
| 08/16/2001 | WO2001058910A2 Lipid-based drug delivery systems |
| 08/16/2001 | WO2001058907A1 Thiazolopyrimidines and their use as modulators of chemokine receptor activity |
| 08/16/2001 | WO2001058906A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 08/16/2001 | WO2001058902A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 08/16/2001 | WO2001058901A1 Pyrrolopyridazine compound |
| 08/16/2001 | WO2001058898A1 Preventive or therapeutic agents for gastric or esophageal regurgitation |
| 08/16/2001 | WO2001058897A1 Benzthiazoles as tnf and pde-iv inhibitors |
| 08/16/2001 | WO2001058896A1 Benzoxazole derivatives as tnf and pde iv inhibitors |
| 08/16/2001 | WO2001058895A1 Benzofuran carboxamides and their therapeutic use |
| 08/16/2001 | WO2001058892A1 Tyrosine derivatives with anti-leukotriene activity |
| 08/16/2001 | WO2001058886A1 Dipeptide nitrile cathepsin k inhibitors |
| 08/16/2001 | WO2001058881A1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 08/16/2001 | WO2001058878A1 2-carboxamide-benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury |
| 08/16/2001 | WO2001058875A2 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives |
| 08/16/2001 | WO2001058852A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8-induced chemiotaxis of neutrophils |
| 08/16/2001 | WO2001058491A1 Drug comprising combination |
| 08/16/2001 | WO2001058488A1 Remedies for sjoegren's syndrome |
| 08/16/2001 | WO2001058465A2 Probiotic therapy for newborns |
| 08/16/2001 | WO2001058448A1 Apoptosis inhibitor |
| 08/16/2001 | WO2001058283A1 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 08/16/2001 | WO2001058241A2 Adenosine a2a receptor antagonists for treating and preventing hepatic fibrosis, cirrhosis and fatty liver |
| 08/16/2001 | WO2001010893A3 Il-16 antagonists |
| 08/16/2001 | WO2001010842A3 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 08/16/2001 | WO2001010413A3 Periodic structures comprising lipids, polyelectrolytes, and structures-inducing soluble oligovalent linkers |
| 08/16/2001 | WO2001009096A3 Potassium channel openers |
| 08/16/2001 | WO2001007628A3 Human synthetases |
| 08/16/2001 | WO2001007595A3 Novel fibroblast growth factor and nucleic acids encoding same |
| 08/16/2001 | WO2001002569A3 Human immune response molecules |
| 08/16/2001 | WO2000066106A3 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 08/16/2001 | US20010014698 Method for preventing and treating alcoholism |
| 08/16/2001 | US20010014689 Nervous system disorders |
| 08/16/2001 | US20010014683 Analgesics; side effect reduction |
| 08/16/2001 | US20010014454 Novel metal complexes |
| 08/16/2001 | US20010014357 Citrus peel extract as inhibitor of ACYL coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases |
| 08/16/2001 | EP1143946A3 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 08/16/2001 | EP1123927A1 Process for the preparation of bis-(4-amino-1-pyridinium)-alkanes |
| 08/16/2001 | EP1123717A2 Estrogen agonist/antagonist and statin containing compositions for treating osteoporosis and lowering cholesterol |
| 08/16/2001 | EP1123709A1 Preventives/remedies for liver diseases |
| 08/16/2001 | EP1123414A1 Antisense modulation of integrin alpha 4 expression |
| 08/16/2001 | EP1123385A2 Human proteins involved in endoplasmic reticulum protein degradation |
| 08/16/2001 | EP1123314A2 USE OF A CYTOKINE-PRODUCING $i(LACTOCOCCUS) STRAIN TO TREAT COLITIS |
| 08/16/2001 | EP1123309A2 Cyclic tetrapeptides and their use as histone deacetylase inhibitor |
| 08/16/2001 | EP1123296A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
| 08/16/2001 | EP1123283A1 Thiazole-derivatives |
| 08/16/2001 | EP1123274A1 Substituted phenyl derivatives, their preparation and use |
| 08/16/2001 | EP1123115A1 Treatment of trauma (ie graft rejection) with liposomes containing dna encoding for ctla4ig or for anti cd40l |
| 08/16/2001 | EP1123109A1 Contulakin-g, analogs thereof and uses therefor |
| 08/16/2001 | EP1123092A2 Fumaric acid microtablets |
| 08/16/2001 | EP1123091A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use |
| 08/16/2001 | EP0839137B1 Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use |
| 08/16/2001 | EP0628042B1 Serotoninergic ergoline derivatives |
| 08/16/2001 | CA2800450A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2416343A1 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 08/16/2001 | CA2400699A1 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 08/16/2001 | CA2400299A1 Dna encoding human vanilloid receptor vr3 |
| 08/16/2001 | CA2399873A1 Drug metabolizing enzymes |
| 08/16/2001 | CA2399821A1 Lipid-based drug delivery systems containing phospholipase a2 degradable lipid derivatives and the therapeutic uses thereof |
| 08/16/2001 | CA2399800A1 Remedies for sjoegren's syndrome |
| 08/16/2001 | CA2399795A1 2-carboxamide-benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury |
| 08/16/2001 | CA2399463A1 Combination drug |
| 08/16/2001 | CA2399391A1 Trade molecules and uses related thereto |
| 08/16/2001 | CA2399387A1 Heterologous polypeptide of the tnf family |
| 08/16/2001 | CA2399380A1 Pyrrolopyridazine compound |
| 08/16/2001 | CA2399148A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2398984A1 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 08/15/2001 | CN1308632A 'Beta'-carboline compound |
| 08/15/2001 | CN1308617A Antiviral macrocyclic compounds |
| 08/15/2001 | CN1308616A Non-peptidyl inhibitors and VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory disease |
| 08/15/2001 | CN1308606A Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use pharmaceutical preparations comprising them |
| 08/15/2001 | CN1308547A Novel compositions |
| 08/15/2001 | CN1308542A Sucoinamide inhibitors of interleukin-1& beta, converting enzyme |
| 08/15/2001 | CN1308540A Anti-diarrheal and method for using the same |
| 08/15/2001 | CN1308531A Vitamin E and esters thereof for use in the topical treatment of mucosal pathologies |
| 08/15/2001 | CN1308069A Substittued (dihydro)benzoxazole and (dihydro)benzoxazine compound and their preparation and medicine composite |
| 08/15/2001 | CN1307906A Medicine targeting carrier |
| 08/15/2001 | CN1307872A Selenium product of natural marine organism and its preparation |
| 08/15/2001 | CN1069542C Medicine for treating chronic hepatism and its preparing process |
| 08/15/2001 | CN1069528C 'Mieyidan' pill for treating hepatitis and producing process thereof |
| 08/15/2001 | CN1069517C Oral compositions |
| 08/15/2001 | CN1069516C Areca catechu medicinal toothpaste composition |
| 08/15/2001 | CA2337381A1 Compositions and methods for treating osteoporosis |
| 08/14/2001 | US6274616 ((3-(2-amino-1,2-dioxoethyl)-1-((1,1'-biphenyl)-3-ylmethyl)-2 -methyl-1h-indol-4-yl)oxy)acetic acid n,n-diethylglycolamidoester used for inhibiting human non-pancreatic secretory phopholipase a2 mediated release of |
| 08/14/2001 | US6274601 Methods of inhibiting ulcerative mucositis |
| 08/14/2001 | US6274588 4-phenyl-pyrimidine derivatives |
| 08/14/2001 | US6274577 Autoimmune diseases; antiinflammatory agents |
| 08/14/2001 | US6274571 Agent for preventing and curing fatty liver and method for curing thereof |
| 08/14/2001 | US6274567 Orally administering high amylose starch |
| 08/14/2001 | US6274559 Liver protection or treatment agents comprising asiatic acid derivatives as the active component |
| 08/14/2001 | US6274556 Administering polypeptide derivative to treat inflammatory bowel disease and to prevent leukocyte infiltration into tissues |
| 08/14/2001 | US6274173 Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole |
| 08/14/2001 | US6274148 Hepatitis C virus asialoglycoproteins |